tiprankstipranks
Trending News
More News >
Globus Medical (GMED)
NYSE:GMED
US Market

Globus Medical (GMED) Stock Forecast & Price Target

Compare
855 Followers
See the Price Targets and Ratings of:

GMED Analyst Ratings

Moderate Buy
15Ratings
10 Buy
5 Hold
0 Sell
Based on 15 analysts giving stock ratings to
Globus
Medical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GMED Stock 12 Month Forecast

Average Price Target

$87.38
▲(42.66% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Globus Medical in the last 3 months. The average price target is $87.38 with a high forecast of $105.00 and a low forecast of $68.00. The average price target represents a 42.66% change from the last price of $61.25.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"49":"$49","106":"$106","63.25":"$63.3","77.5":"$77.5","91.75":"$91.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":105,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$105.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":87.38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$87.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":68,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$68.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[49,63.25,77.5,91.75,106],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.11,73.71692307692308,76.32384615384615,78.93076923076923,81.53769230769231,84.14461538461538,86.75153846153846,89.35846153846154,91.96538461538461,94.57230769230769,97.17923076923077,99.78615384615384,102.39307692307692,{"y":105,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.11,72.36153846153846,73.61307692307692,74.86461538461538,76.11615384615385,77.36769230769231,78.61923076923077,79.87076923076923,81.12230769230769,82.37384615384615,83.6253846153846,84.87692307692308,86.12846153846154,{"y":87.38,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.11,70.87076923076923,70.63153846153845,70.3923076923077,70.15307692307692,69.91384615384615,69.67461538461538,69.43538461538462,69.19615384615385,68.95692307692308,68.7176923076923,68.47846153846154,68.23923076923077,{"y":68,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":50.43,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.11,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.92,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.1,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.7,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.4,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.88,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.9,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.71,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.72,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.32,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.39,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.11,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$105.00Average Price Target$87.38Lowest Price Target$68.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on GMED
Richard NewitterTruist Financial
Truist Financial
$80$68
Hold
11.02%
Upside
Reiterated
05/12/25
Oppenheimer Analyst forecast on GMED
Steven LichtmanOppenheimer
Oppenheimer
$90$78
Hold
27.35%
Upside
Reiterated
05/09/25
Stifel Nicolaus Analyst forecast on GMED
Mathew BlackmanStifel Nicolaus
Stifel Nicolaus
$94$70
Buy
14.29%
Upside
Reiterated
05/09/25
Roth MKM Analyst forecast on GMED
Jason WittesRoth MKM
Roth MKM
$115$105
Buy
71.43%
Upside
Reiterated
05/09/25
Bank of America Securities Analyst forecast on GMED
Craig BijouBank of America Securities
Bank of America Securities
$97$78
Hold
27.35%
Upside
Reiterated
05/09/25
Wells Fargo Analyst forecast on GMED
Vik ChopraWells Fargo
Wells Fargo
$93$76
Buy
24.08%
Upside
Reiterated
05/09/25
RBC Capital
$101$95
Buy
55.10%
Upside
Reiterated
05/09/25
Needham
Hold
Reiterated
05/09/25
Piper Sandler Analyst forecast on GMED
Matthew O'BrienPiper Sandler
Piper Sandler
$100$80
Buy
30.61%
Upside
Reiterated
05/09/25
BTIG
$88$77
Buy
25.71%
Upside
Reiterated
05/09/25
Barclays Analyst forecast on GMED
Matt MiksicBarclays
Barclays
$103
Buy
68.16%
Upside
Reiterated
05/08/25
Morgan Stanley Analyst forecast on GMED
Kallum TitchmarshMorgan Stanley
Morgan Stanley
$100
Buy
63.27%
Upside
Reiterated
05/08/25
Canaccord Genuity Analyst forecast on GMED
Caitlin CroninCanaccord Genuity
Canaccord Genuity
$101
Buy
64.90%
Upside
Reiterated
04/25/25
Jefferies
$105
Buy
71.43%
Upside
Reiterated
04/14/25
Citizens JMP Analyst forecast on GMED
David TurkalyCitizens JMP
Citizens JMP
Hold
Reiterated
04/10/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on GMED
Richard NewitterTruist Financial
Truist Financial
$80$68
Hold
11.02%
Upside
Reiterated
05/12/25
Oppenheimer Analyst forecast on GMED
Steven LichtmanOppenheimer
Oppenheimer
$90$78
Hold
27.35%
Upside
Reiterated
05/09/25
Stifel Nicolaus Analyst forecast on GMED
Mathew BlackmanStifel Nicolaus
Stifel Nicolaus
$94$70
Buy
14.29%
Upside
Reiterated
05/09/25
Roth MKM Analyst forecast on GMED
Jason WittesRoth MKM
Roth MKM
$115$105
Buy
71.43%
Upside
Reiterated
05/09/25
Bank of America Securities Analyst forecast on GMED
Craig BijouBank of America Securities
Bank of America Securities
$97$78
Hold
27.35%
Upside
Reiterated
05/09/25
Wells Fargo Analyst forecast on GMED
Vik ChopraWells Fargo
Wells Fargo
$93$76
Buy
24.08%
Upside
Reiterated
05/09/25
RBC Capital
$101$95
Buy
55.10%
Upside
Reiterated
05/09/25
Needham
Hold
Reiterated
05/09/25
Piper Sandler Analyst forecast on GMED
Matthew O'BrienPiper Sandler
Piper Sandler
$100$80
Buy
30.61%
Upside
Reiterated
05/09/25
BTIG
$88$77
Buy
25.71%
Upside
Reiterated
05/09/25
Barclays Analyst forecast on GMED
Matt MiksicBarclays
Barclays
$103
Buy
68.16%
Upside
Reiterated
05/08/25
Morgan Stanley Analyst forecast on GMED
Kallum TitchmarshMorgan Stanley
Morgan Stanley
$100
Buy
63.27%
Upside
Reiterated
05/08/25
Canaccord Genuity Analyst forecast on GMED
Caitlin CroninCanaccord Genuity
Canaccord Genuity
$101
Buy
64.90%
Upside
Reiterated
04/25/25
Jefferies
$105
Buy
71.43%
Upside
Reiterated
04/14/25
Citizens JMP Analyst forecast on GMED
David TurkalyCitizens JMP
Citizens JMP
Hold
Reiterated
04/10/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Globus Medical

Which Analyst Should I Follow If I Want to Buy GMED and Sell After:
1 Month
xxx
Success Rate
12/21 ratings generated profit
57%
Average Return
+1.44%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +1.44% per trade.
3 Months
xxx
Success Rate
16/24 ratings generated profit
67%
Average Return
+4.95%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.95% per trade.
1 Year
Matt MiksicBarclays
Success Rate
20/32 ratings generated profit
63%
Average Return
+11.75%
reiterated a buy rating 11 days ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +11.75% per trade.
2 Years
xxx
Success Rate
26/32 ratings generated profit
81%
Average Return
+20.60%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 81.25% of your transactions generating a profit, with an average return of +20.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GMED Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
0
0
1
1
3
Buy
27
37
34
27
16
Hold
8
10
11
10
8
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
36
47
46
38
27
In the current month, GMED has received 19 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. GMED average Analyst price target in the past 3 months is 87.38.
Each month's total comprises the sum of three months' worth of ratings.

GMED Financial Forecast

GMED Earnings Forecast

Next quarter’s earnings estimate for GMED is $0.79 with a range of $0.72 to $0.89. The previous quarter’s EPS was $0.68. GMED beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.28% of the time in the same period. In the last calendar year GMED has Outperformed its overall industry.
Next quarter’s earnings estimate for GMED is $0.79 with a range of $0.72 to $0.89. The previous quarter’s EPS was $0.68. GMED beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.28% of the time in the same period. In the last calendar year GMED has Outperformed its overall industry.

GMED Sales Forecast

Next quarter’s sales forecast for GMED is $733.50M with a range of $670.00M to $763.60M. The previous quarter’s sales results were $598.12M. GMED beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year GMED has Outperformed its overall industry.
Next quarter’s sales forecast for GMED is $733.50M with a range of $670.00M to $763.60M. The previous quarter’s sales results were $598.12M. GMED beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year GMED has Outperformed its overall industry.

GMED Stock Forecast FAQ

What is GMED’s average 12-month price target, according to analysts?
Based on analyst ratings, Globus Medical’s 12-month average price target is 87.38.
    What is GMED’s upside potential, based on the analysts’ average price target?
    Globus Medical has 42.66% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GMED a Buy, Sell or Hold?
          Globus Medical has a consensus rating of Moderate Buy which is based on 10 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Globus Medical’s price target?
            The average price target for Globus Medical is 87.38. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $105.00 ,the lowest forecast is $68.00. The average price target represents 42.66% Increase from the current price of $61.25.
              What do analysts say about Globus Medical?
              Globus Medical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of GMED?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis